Edition:
United States

ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

3.30USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$3.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,236
52-wk High
$5.88
52-wk Low
$2.20

Chart for

About

ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $12.93
Shares Outstanding(Mil.): 3.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 187.16 16.73
EPS (TTM): -- -- --
ROI: -- -0.71 35.60
ROE: -- -3.52 17.23

BRIEF-Endra Life Sciences Enters Into Amendment To Certain Collaborative Research Agreement With GE

* ENDRA LIFE SCIENCES INC - ON JAN 30, CO ENTERED INTO AMENDMENT TO CERTAIN COLLABORATIVE RESEARCH AGREEMENT WITH GE, DATED AS OF APRIL 22, 2016

Feb 05 2018

BRIEF-ENDRA Life Sciences reports Q3 loss per share $0.23

* Q3 loss per share $0.23 Source text: [http://bit.ly/2ANFlXF] Further company coverage:

Nov 15 2017

Earnings vs. Estimates

No consensus analysis data available.